Has it been stated or has anyone guessed how much a B OM phase 3 would be? I wouldn't think too expensive. Maybe phase 3 is delayed partially due to number of patients available but certainly lack of funding is the reason. Seems we would split the trial and run part through Europe using a partner for Europe.